Short answer: Willow sells compounded semaglutide for $299 a month all-in, and Hims sells FDA-approved GLP-1s from $298 a month all-in. For…
September 22, 2026
MadeMed
Quick verdict
- Best for
- cash-pay users comparing a multi-condition online prescription platform with published treatment starting prices
- Key feature
- MadeMed is a telehealth platform connecting patients with an independent medical group and partner pharmacies. Its public catalog includes weight-loss options (injectable and oral semaglutide and tirzepatide), sexual-health medication, peptide and NAD+ offerings. MadeMed says it does not itself provide medical care; the independent clinicians make the prescribing decision.
MadeMed is best understood as MadeMed is a telehealth platform connecting patients with an independent medical group and partner pharmacies. Its public catalog includes weight-loss options (injectable and oral semaglutide and tirzepatide), sexual-health medication, peptide and NAD+ offerings. MadeMed says it does not itself provide medical care; the independent clinicians make the prescribing decision. Published pricing: The public catalog listed compounded injectable semaglutide from $199/month, oral semaglutide from $179/month, injectable tirzepatide from $369/month and oral tirzepatide from $279/month when checked. These are starting prices; check dose, subscription duration, pharmacy, shipping and whether follow-up is included. Its terms state charges recur every 30 or 90 days until cancellation; cancellations are effective at the period’s end and prorated refunds are not offered. This review evaluates public information and service transparency, not clinical outcomes. We did not purchase care or test medication.
Our rating
Pros and cons
Pros
- cash-pay users comparing a multi-condition online prescription platform with published treatment starting prices
- Public materials provide useful pre-enrollment information.
- Online access can be convenient for eligible users.
Cons
- Cash-pay only according to the terms reviewed; availability can vary by state. Compounded prescriptions are not FDA-approved products. Confirm exact medicine and dispensing pharmacy with the clinician before purchase.
- The public catalog listed compounded injectable semaglutide from $199/month, oral semaglutide from $179/month, injectable tirzepatide from $369/month and oral tirzepatide from $279/month when checked. These are starting prices; check dose, subscription duration, pharmacy, shipping and whether follow-up is included. Its terms state charges recur every 30 or 90 days until cancellation; cancellations are effective at the period’s end and prorated refunds are not offered.
- Public claims do not guarantee individual medical results.
About this product
MadeMed is a telehealth platform connecting patients with an independent medical group and partner pharmacies. Its public catalog includes weight-loss options (injectable and oral semaglutide and tirzepatide), sexual-health medication, peptide and NAD+ offerings. MadeMed says it does not itself provide medical care; the independent clinicians make the prescribing decision.
How it compares
Short answer: both mainly sell compounded GLP-1s, which are not FDA-approved. Mochi Health is cheaper at low doses, from $139 a month…
September 22, 2026
Short answer: Hims and Noom are different kinds of programs. Hims sells FDA-approved brand-name GLP-1s with a $149 membership, from $298 a…
September 22, 2026
User reviews
No user reviews yet.